Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

387

Enrollment

INDUSTRY

Sponsor class

Conditions

Acellular Pertussis
Poliomyelitis
Tetanus
Diphtheria

Interventions

BIOLOGICAL: Boostrix PolioTM
BIOLOGICAL: RepevaxTM
BIOLOGICAL: PriorixTM

Sponsor

GlaxoSmithKline